Veeda Lifesciences

Behind every successful biosimilar lies a story of precision, perseverance, and advanced science. When an Indian pharmaceutical company set out to develop a biosimilar of Denosumab—a monoclonal antibody, critical for treating osteoporosis and cancer-related bone loss—they knew that proving structural and functional similarities were non-negotiable. That’s where Veeda Lifesciences stepped in. From molecular mass to glycoforms, from disulfide linkages to secondary structure integrity—we left no data point unexplored. Our scientists took on challenges like glycoform variability, peptide mapping complexity, and intact mass determination head-on, using tools like: ·  Q Exactive Orbitrap for in-depth LC-MS analysis ·  Applied Photophysics CD Spectroscopy for structural conformation ·  Enzymatic digestion, targeted reduction, and internal calibration for unmatched precision The result? ·  Test and reference products matched closely across all parameters ·  High sequence coverage with no unexpected modifications ·  Consistent glycan profiles and disulfide patterns ·  Confirmed structural similarity via CD spectral fingerprints The study not only met expectations—it reinforced confidence in biosimilar development and regulatory readiness. This is how we at Veeda Lifesciences help transform complex molecules into clinical possibilities. To learn more about biosimilars, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #Biosimilars #Denosumab #ProteinCharacterization #CDSpectroscopy #LCMS #MonoclonalAntibodies #Bioanalytics #ClinicalDevelopment #BiopharmaExcellence #VeedaLifesciences

Join Veeda Lifesciences' Phase I experts for our upcoming webinar on Designing Phase I Trials for Biosimilars that'll cover: 1️⃣ Expert Insights: Learn from Veeda Lifesciences' studies and experiences in biosimilar development. 2️⃣ Strategic Approaches: Explore key strategies for dose escalation, PK/PD assessments, and immunogenicity monitoring. 3️⃣ Adaptive Trial Design: Discover adaptive trial designs, real-time data adjustments, and effective risk mitigation approaches. 4️⃣ Regulatory Navigation: Gain insights into aligning study protocols with evolving global regulatory requirements Register Now: https://lnkd.in/dhtMx7nr Excellence in Everything #VeedaLifesciences #Veeda #Phase1webinar #Phase1Trials #Biosimilars #Webinar #ExcellenceInEverything

Supporting Breakthroughs in Myeloma Science — Veeda Lifesciences is Sponsoring 6th European Myeloma Network Meeting. While treatments for hematological cancers have made headway, there's still a long way to go. Veeda Lifesciences is driven by the same hope for better outcomes and is honored to sponsor the 6th European Myeloma Network Meeting in Athens (April 10-12, 2025). With our years of experience in hematologic malignancies, we have witnessed firsthand the transformative impact of scientific advancements on treatment strategies and patient care. If you're heading to 6th European Multiple Myeloma Network Meeting in Athens, drop by our booth no 7. Book a meeting now – https://bit.ly/4gCPpFH To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #VeedaLifesciences #MyelomaScience #MultipleMyeloma #TreatmentStrategies #ScientificAdvancement #Veeda #EMN2025

Designing Phase I Trials for Biosimilars: Unique Challenges and Strategies Join Veeda Lifesciences' Phase I experts as they share in-depth knowledge and insights in our upcoming webinar on designing Phase I trials for biosimilars. 𝐃𝐚𝐭𝐞: 8th May, 2025 𝐓𝐢𝐦𝐞: 6:30 PM IST | 4:00 PM EEST | 9:00 AM EDT 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦: Zoom Webinar Highlights: 1️⃣ Expert Insights: Learn from Veeda Lifesciences' studies and experiences in biosimilar development. 2️⃣ Strategic Approaches: Explore key strategies for dose escalation, PK/PD assessments, and immunogenicity monitoring. 3️⃣ Adaptive Trial Design: Discover adaptive trial designs, real-time data adjustments, and effective risk mitigation approaches. 4️⃣ Regulatory Navigation: Gain insights into aligning study protocols with evolving global regulatory requirements Register Now: https://lnkd.in/dhtMx7nr To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #VeedaLifesciences #Veeda #Phase1webinar #Phase1Trials #Biosimilars #Webinar #ExcellenceInEverything

Every Breakthrough Starts with a Question. How can we accelerate drug development? How can we bring safe, effective therapies to patients faster? At Veeda Lifesciences, we ask these questions every day—and we answer them with science, innovation, and collaboration. As we gear up for BIO International Convention 2025 (June 16-19, Boston), we look forward to connecting with industry leaders who share our vision for advancing drug development.   Advancing Drug Development for Over Two Decades. With 20 years of experience, Veeda Lifesciences has built a strong foundation in bioanalytical sciences, biologics, biosimilars, and clinical research. Our expertise spans: ·      Discovery & Preclinical – Assay biology, DMPK/ADME, and bioanalytical support ·      Biopharma Development – Cell line development, process optimization, and characterization ·      Clinical Research – Phase I-IV trials, PK/PD, immunogenicity, and biomarker analysis ·      Regulatory Support – Ensuring compliance and smooth submissions across global markets With state-of-the-art infrastructure and teams across the USA, EU, and Asia-Pacific, we provide the expertise and capabilities to accelerate your drug development journey.   Meet Us at Booth 3285/1 in Boston! Let’s discuss how Veeda Lifesciences can support your pipeline—whether you’re in early discovery or late-stage clinical trials. Secure your meeting slot today! https://bit.ly/4gCPpFH Together, let’s bring the next breakthrough to life. To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #BIOInternationalConvention #VeedaLifesciences #Biopharma #DrugDevelopment #ClinicalResearch #Biosimilars #BiotechInnovation

The latest issue is out! Read the Veeda Newsletter March 2025 Edition here - https://bit.ly/4hX9CXq Excellence in Everything #Veeda #VeedaLifesciences #TheVeedaLifesciencesNewsletter #March2025 #MarchEdition

Veeda Lifesciences wishes you and your loved ones an Eid filled with Joy and Happiness! Excellence in Everything #Eid #EidMubarak #EidMubarak2025 #Veeda #VeedaLifesciences

At Veeda Lifesciences, we offer an extensive portfolio of validated bioanalytical assays to support Generics, NCEs, and Biotherapeutics across various platforms like LC/MS/MS. From pharmacokinetics (PK) to immunogenicity and biomarker analysis, our assays deliver reliable, high-quality data for every phase of drug development. Explore the complete list here: https://bit.ly/4hT9YPt To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com. Excellence in Everything #Bioanalysis #DrugDevelopment #Pharmacokinetics #ClinicalResearch #AssayValidation #Biotherapeutics #VeedaBiopharma

Every breakthrough drug starts as a complex molecular blueprint—one that must be meticulously understood, tested, and refined before it reaches patients. But the journey from discovery to approval is filled with challenges: structural variations, stability concerns, and regulatory hurdles. At Veeda Lifesciences, we go beyond routine analysis. As Experts in Analytical Sciences, we transform raw data into actionable insights, accelerating drug development with precision-driven CMC analytical services. Imagine developing a promising biotherapeutic. You need to confirm its primary structure, ensure its higher-order stability, and characterize its molecular profile, all while meeting regulatory expectations. Our state-of-the-art techniques provide: • High-Resolution Mass Spectrometry (HRMS) and Liquid Chromatography for in-depth protein analysis • Advanced biophysical methods to evaluate stability and integrity • Rapid N-Glycan Analysis in just 3–4 days, cutting down processing time from weeks to days With expert scientists, cutting-edge infrastructure, and regulatory-ready data, Veeda Lifesciences helps you navigate the complexities of biopharmaceutical development with confidence. Learn more about our capabilities: https://bit.ly/4lbQBDt To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com. Excellence in Everything #AnalyticalSciences #CMCAnalytics #Biopharma #StructuralCharacterization #VeedaLifesciences #Biologics #Veeda

As an intravenous iron replacement therapy, Ferric carboxymaltose supports the treatment of iron deficiency in anemia, especially for those who cannot tolerate or respond to oral supplements.   The USFDA had  recently introduced bioequivalence study guidelines & Veeda Lifesciences is stepping up to lead the charge by offering full-spectrum, regulatory-aligned study solutions for both adult patients and healthy subject. With a high success rate and a strong portfolio of meticulously designed studies, our scientific leadership team is committed to optimizing drug development processes while ensuring patient safety and data accuracy on a global scale. To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #FerricCarboxymaltose #DrugDevelopment #BioequivalenceStudy #Veeda #VeedaLifesciences #ClinicalTrials